Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
values decrease » values increased (Expand Search)
linear decrease » linear increase (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
values decrease » values increased (Expand Search)
linear decrease » linear increase (Expand Search)
-
4961
-
4962
Table 1_Distinct response patterns of endothelial markers to the BNT162b2 mRNA COVID-19 booster vaccine are associated with the spike-specific IgG antibody production.docx
Published 2025“…To analyze each participant´s individual response, we calculated relative increases/decreases (delta values) in endothelial markers and antibodies concentrations compared to their pre-vaccination levels.…”
-
4963
-
4964
-
4965
-
4966
The system under study.
Published 2025“…Three test systems (TS) are used to validate the HBF’s superiority in mitigating the harmonics, minimizing PLOSS, and maximizing HCHC. In TS1, the SFS-optimized HBF decreases <i>THD</i><sub><i>V</i></sub> by 78% and <i>TDD</i><sub><i>I</i></sub> by 90% while maintaining <i>P</i><sub><i>LOSS</i></sub> almost the same as compared to the previously obtained results in the literature. …”
-
4967
TS2 parameters.
Published 2025“…Three test systems (TS) are used to validate the HBF’s superiority in mitigating the harmonics, minimizing PLOSS, and maximizing HCHC. In TS1, the SFS-optimized HBF decreases <i>THD</i><sub><i>V</i></sub> by 78% and <i>TDD</i><sub><i>I</i></sub> by 90% while maintaining <i>P</i><sub><i>LOSS</i></sub> almost the same as compared to the previously obtained results in the literature. …”
-
4968
TS3 parameters.
Published 2025“…Three test systems (TS) are used to validate the HBF’s superiority in mitigating the harmonics, minimizing PLOSS, and maximizing HCHC. In TS1, the SFS-optimized HBF decreases <i>THD</i><sub><i>V</i></sub> by 78% and <i>TDD</i><sub><i>I</i></sub> by 90% while maintaining <i>P</i><sub><i>LOSS</i></sub> almost the same as compared to the previously obtained results in the literature. …”
-
4969
HBF design parameters for TS3.
Published 2025“…Three test systems (TS) are used to validate the HBF’s superiority in mitigating the harmonics, minimizing PLOSS, and maximizing HCHC. In TS1, the SFS-optimized HBF decreases <i>THD</i><sub><i>V</i></sub> by 78% and <i>TDD</i><sub><i>I</i></sub> by 90% while maintaining <i>P</i><sub><i>LOSS</i></sub> almost the same as compared to the previously obtained results in the literature. …”
-
4970
HBF design parameters for TS2.
Published 2025“…Three test systems (TS) are used to validate the HBF’s superiority in mitigating the harmonics, minimizing PLOSS, and maximizing HCHC. In TS1, the SFS-optimized HBF decreases <i>THD</i><sub><i>V</i></sub> by 78% and <i>TDD</i><sub><i>I</i></sub> by 90% while maintaining <i>P</i><sub><i>LOSS</i></sub> almost the same as compared to the previously obtained results in the literature. …”
-
4971
HBF design results minimize P<sub>LOSS</sub> in TS3.
Published 2025“…Three test systems (TS) are used to validate the HBF’s superiority in mitigating the harmonics, minimizing PLOSS, and maximizing HCHC. In TS1, the SFS-optimized HBF decreases <i>THD</i><sub><i>V</i></sub> by 78% and <i>TDD</i><sub><i>I</i></sub> by 90% while maintaining <i>P</i><sub><i>LOSS</i></sub> almost the same as compared to the previously obtained results in the literature. …”
-
4972
-
4973
-
4974
-
4975
-
4976
Epidemiology of Orbital and Preseptal Cellulitis in the United States: A 13-Year Analysis
Published 2025“…Incidence rates, descriptive statistics, and risk factors were calculated using linear and multivariate logistic regression models.…”
-
4977
-
4978
-
4979
-
4980
Association between circulating irisin level and depression: a systematic review and meta-analysis
Published 2025“…Subgroup analysis revealed decreased irisin levels in depressive Asian patients (SMD = 0.47, 95% CI: 0.05 to 0.90, <i>p</i> = 0.03), sample size greater than 100 participants (SMD = 1.20, 95% CI: 0.48 to 1.93, <i>p</i> = 0.001), ELISA kits not from Phoenix Pharmaceuticals (SMD = 0.47, 95% CI: 0.05 to 0.90, <i>p</i> = 0.03), blood sample of serum (SMD = 0.79, 95% CI: 0.18 to 1.40, <i>p</i> = 0.01), studies with two genders (SMD = 0.85, 95% CI: 0.26 to 1.43, <i>p</i> = 0.005). …”